Ncardia's Remarkable Journey in 2023: A Year of Growth, Innovation, and Leadership
Ncardia Welcomes Divisional CEO, Dr. Jeroen de Groot
Development of next generation of high-tech equipment for cell culture applications.
Press release: Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial Officer
Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy Treatment
The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models